Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

2 235 evidences · page 31 / 90

1 723 individualsAmong 11,070 people with HIV (PWH) with AUDIT-C measured, 1723 (16%) reported any alcohol use.

KenyaVIH/sidapublié 2023Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 6 observations

28 %Of 25 participants with incident HIV infection, 7/25 (28%) reported taking PrEP ≤30 days before HIV diagnosis.

KenyaVIH/sidapublié 2021PLoS medicinePubMeddocument de 12 observations

Among persons with HIV on long-term antiretroviral therapy, higher BMI >30 kg/m2 was associated with hypertension.

Kenyahypertension artérielle · VIH/sidaobservé September 2017 to May 2018publié 2022PloS onePubMeddocument de 6 observations

55 %Most of the anaemia was dimorphic in HIV-negative non-injection substance users (55%).

Kenyaanémie · VIH/sidapublié 2022African health sciencesPubMeddocument de 7 observations

1,93 aPRPast physical violence was significantly associated with a higher prevalence of intimate partner violence in the past year among women with HIV in serodifferent relationships in Nairobi, Kenya, with an adjusted prevalence ratio of 1.93.

KenyaVIH/sidapublié 2022PloS onePubMeddocument de 8 observations

57,6 %Among 720 participants living with HIV in southwestern Kenya, 57.6% of women reported experiencing intimate partner violence.

KenyaVIH/sidaobservé January 2016-December 2017publié 2021American journal of preventive medicinePubMeddocument de 6 observations

34 seroconversionsThirty-four seroconversions occurred within 30 days of PrEP initiation.

KenyaVIH/sidaobservé December 2017 through September 2023publié 2025Journal of the International AIDS SocietyPubMeddocument de 13 observations

0,4 %Among HIV-1 seropositive women prostitutes in Nairobi (Kenya), 0.4% had hairy leukoplakia as the only oral lesion.

Kenyahairy leukoplakia · VIH/sidapublié 1989Journal of Oral Pathology and MedicineOpenAlexdocument de 8 observations

1,52 fold_increaseTrichomoniasis was associated with a 1.52-fold increased risk of HIV-1 acquisition after adjustment for potential confounding factors among HIV-1-seronegative women in Mombasa, Kenya.

Kenyatrichomoniasis · VIH/sidapublié 2007The Journal of infectious diseaseseurope_pmcdocument de 3 observationsDOI 10.1086/511278

1,1 %Among HIV-1 seropositive women prostitutes in Nairobi (Kenya), 1.1% had hyperplastic candidiasis as the only oral lesion.

Kenyahyperplastic candidiasis · VIH/sidapublié 1989Journal of Oral Pathology and MedicineOpenAlexdocument de 8 observations

97 %Among ART-experienced persons with baseline viral suppression, viral suppression at year 3 was 97% in the intervention arm and 95% in the control arm.

KenyaVIH/sidapublié 2020Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 4 observations

4,7 %Few pregnant women living with HIV in Kenya reported delaying antenatal care because of COVID-19 (4.7%).

KenyaCOVID-19 · VIH/sidaobservé October 2020 to July 2022publié 2024BMC pregnancy and childbirthPubMeddocument de 4 observations

592 000 individualsIn 2018, the model projected 592,000 individuals in need of antiretroviral therapy (ART) in Kenya.

KenyaVIH/sidaobservé 2018publié 2020Journal of the International AIDS SocietyPubMeddocument de 10 observations

4,54 relative_riskMaternal non-disclosure of HIV status to partner(s) was associated with a relative risk of 4.54 for infant HIV positivity at 12 months.

KenyaVIH/sidaobservé 12 monthspublié 2023European Journal of Public HealthOpenAlexdocument de 7 observationsDOI 10.1093/eurpub/ckad160.824

80 %The mean proportion of participants with virological suppression at 2 years was 80% for participants in control clinics.

KenyaVIH/sidapublié 2023The lancet. HIVPubMeddocument de 8 observations

62 %Overall, 62% of vaccine recipients in the rAd5 alone group responded to the HIV-1 proteins by an interferon-gamma (IFN-γ) ELISPOT.

KenyaVIH/sidapublié 2010PloS oneeurope_pmcdocument de 4 observations

-0,04 percentage_pointsThe difference in percentage of participants meeting the primary end point between the dolutegravir and ritonavir-boosted PI groups was -0.04 percentage points at week 48.

KenyaVIH/sidaobservé week 48publié 2023The New England journal of medicinePubMeddocument de 8 observations

11 %Among children living with HIV who were active on treatment, those who aged out of childhood ranged between 11% and 13%.

KenyaVIH/sidapublié 2025The Pediatric infectious disease journalPubMeddocument de 10 observations

2,76 aORUsing opioid agonist therapy was associated with increased ART coverage among people living with HIV (adjusted odds ratio = 2.76; 95% CI: 1.50–5.06).

KenyaVIH/sidapublié 2025The International journal on drug policyPubMeddocument de 10 observations

18 individualsAmong 348 women in a 2-year study of young women at high HIV risk in Thika and Kisumu, Kenya, 18 (5%) followed a steady high PrEP adherence trajectory.

KenyaVIH/sidapublié 2023AIDS and behaviorPubMeddocument de 5 observations

4,5 %HIV prevalence was 4.5% among adolescent girls and young women aged 15–24 years in western Kenya in 2018.

KenyaVIH/sidaobservé 2018publié 2022Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 4 observations

81,9 %At 3 years, child HIV-free survival was 81.9% overall, 92.0% for children of women retained in care (RW), and 58.6% for children of women lost to follow-up (LW).

KenyaVIH/sidapublié 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 13 observations

1,8 relative_riskCompared with the $0 arm, caregivers in the $10.00 arm had significantly higher uptake of child HIV testing, with a relative risk of 1.80 (95% CI 1.15–2.80), P = 0.010.

KenyaVIH/sidapublié 2021AIDS (London, England)PubMeddocument de 3 observations

64 %Sixty-four percent of HIV-1-negative volunteers were positive for Plasmodium 18S, corresponding to 998 out of 1,569 individuals.

Kenyapaludisme · VIH/sidapublié 2021The American journal of tropical medicine and hygienePubMeddocument de 7 observations

2 casesTwo HIV seroconversions occurred during follow-up: one at 12 months and one at 18 months of follow-up.

KenyaVIH/sidapublié 2026AIDS and behaviorPubMeddocument de 10 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.